Navigation Links
Cell Line Nucleofector Kit V from Lonza Cologne AG

ProductsCell Line Nucleofector Kit V from Lonza Cologne AG
Company Lonza Cologne AG
Item Cell Line Nucleofector Kit V
Price 
Description For nucleofection of optimized cell lines in combination with the corresponding optimized protocol including the nucleofection parameters. Nucleofector Kits are only functional in combination with the Nucleofector Device.

Different cell lines can be transfected with this kit. The corresponding efficiencies and viabilities are given in brackets in percent (Efficiency [%] / viability [%]).

Cell Lines:
3T3-L1 pre-ad (73/59)
293 (ATCC) (84/---)
293 (DSMZ) (57/---)
32D (ATCC) (79/61)
A20 (ATCC) (74/81)
AGS (ATCC) (73/62)
ARPE-19 (ATCC) (83/92)
BA/F3 (DSMZ) (88/80)
C2C12 (ATCC) (82/67)
C6 (ATCC) (87/80)
COS-1 (ATCC) (49/64)
COS-7 (DSMZ) (85/---)
HaCaT (DKFZ) (43/---)
HCT116 (ATCC) (78/50)
HepG2 (64/---)
HL-60 (ATCC) (50/---)
Jurkat (ATCC) (54/---)
Jurkat (DSMZ) (68/---)
K562 (ATCC) (89/---)
K562 (DSMZ) (79/---)
MCF-7 (ATCC) (71/---)
MDA-MB231 (ATCC) (80/77)
MDA-MB468 (ATCC) (60/94)
NCTC clone 929 (ATCC) (67/91)
Neuro-2a (ATCC) (76/79)
P19 (ATCC) (85/80)
PC12 (34/---)
PC-3 (ATCC) (81/60)
Raji (ATCC) (58/67)
Ramos (ATCC) (27/72)
RAW 264.7 (65/74)
RBL-1 (ATCC) (84/67)
Saos-2 (ATCC) (82/79)
SH-SY5Y (ATCC) (82/60)
SK-N-SH (ATCC) (85/73)
SK-OV-3 (ATCC) (89/60)
sus.CHO (ECACC) (92/80)
SW480 (ATCC) (60/86)
T-47D (ATCC) (51/94)
THP-1 (ATCC) (67/60)
U-2 OS (ATCC) (98/88)
U937 (ATCC) (56/50)
Vero (ATCC) (79/97)

If your cell line is not listed, please consult our cell database at the link below.

Info Lonza Cologne AG

Nattermannallee 1
50829 Koeln
Germany

Customer Service: 49 (0)221-99199-0
Fax Number: 49 (0)221-99199-111
Web Site: http://www.lonza.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Cell Line Nucleofector Kit T from Lonza Cologne AG
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... Monoclonal Antibody, Unconjugated Applications: ... ICC: Use at an assay dependent dilution. WB: ... ug/ml, this concentration is determined using a whole ... kDa. Not tested in other applications. Optimal ...
SHP-2 Antibody...
... 2, Neuronal (GLYT2). The antiserum has been ... nervous system. The staining pattern obtained with ... in situ hybridization with probes to GLYT2 ... for glycinergic neurons. Preabsorption of the antiserum ...
Biology Products:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) and ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
Breaking Biology Technology: